Holen Sie sich die Stockscreener-App
26.45
4.13%
1.05
Handel nachbörslich:
26.47
0.02
+0.08%
Schlusskurs vom Vortag:
$25.40
Offen:
$25.36
24-Stunden-Volumen:
2.36M
Relative Volume:
1.40
Marktkapitalisierung:
$1.51B
Einnahmen:
$308.05M
Nettoeinkommen (Verlust:
$-95.57M
KGV:
-15.38
EPS:
-1.72
Netto-Cashflow:
$-58.34M
1W Leistung:
+6.52%
1M Leistung:
+14.01%
6M Leistung:
-15.60%
1J Leistung:
-50.21%
1-Tages-Spanne:
$25.00
$27.81
1-Wochen-Bereich:
$24.25
$27.81
52-Wochen-Spanne:
$19.35
$66.85
Procept Biorobotics Corp Stock (PRCT) Company Profile
Firmenname
Procept Biorobotics Corp
Sektor
Branche
Telefon
(650) 232-9832
Adresse
150 BAYTECH DRIVE, SAN JOSE
Compare PRCT vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRCT
Procept Biorobotics Corp
|
26.45 | 1.45B | 308.05M | -95.57M | -58.34M | -1.72 |
ABT
Abbott Laboratories
|
82.56 | 146.87B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
282.58 | 109.33B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
74.54 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
53.37 | 80.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
77.17 | 46.04B | 6.30B | 1.07B | 1.09B | 1.8406 |
Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-06 | Eingeleitet | Robert W. Baird | Neutral |
| 2026-02-26 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2026-02-26 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-12-12 | Eingeleitet | UBS | Buy |
| 2025-12-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-09-02 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2025-07-09 | Eingeleitet | Stephens | Overweight |
| 2025-07-07 | Eingeleitet | Oppenheimer | Perform |
| 2024-12-02 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-11-14 | Eingeleitet | Jefferies | Hold |
| 2023-08-11 | Eingeleitet | Piper Sandler | Overweight |
| 2023-05-31 | Eingeleitet | William Blair | Outperform |
| 2022-10-31 | Eingeleitet | BTIG Research | Neutral |
| 2022-10-25 | Eingeleitet | Truist | Buy |
| 2022-09-02 | Eingeleitet | Wells Fargo | Overweight |
| 2022-07-15 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-06-23 | Eingeleitet | B. Riley Securities | Buy |
| 2021-10-11 | Eingeleitet | BofA Securities | Buy |
| 2021-10-11 | Eingeleitet | Cowen | Outperform |
| 2021-10-11 | Eingeleitet | Goldman | Neutral |
| 2021-10-11 | Eingeleitet | Guggenheim | Buy |
| 2021-10-11 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Procept Biorobotics Corp Aktie (PRCT) Neueste Nachrichten
Should PROCEPT BioRobotics’ Reaffirmed 2026 Outlook Amid Wider Losses Require Action From PRCT Investors? - simplywall.st
C WorldWide Group Holding A S Purchases 225,000 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
UBS Group AG Increases Position in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
A Look At PROCEPT BioRobotics (PRCT) Valuation After Q1 Earnings And Reaffirmed Growth Guidance - Sahm
Does Stronger Aquablation Tailwinds And Reaffirmed 2026 Guidance Change The Bull Case For PROCEPT (PRCT)? - Sahm
PRCT SEC FilingsProcept Biorobotics Corp 10-K, 10-Q, 8-K Forms - Stock Titan
PRCT Stock Price, Quote & Chart | PROCEPT BIOROBOTICS CORP (NASDAQ:PRCT) - ChartMill
How The PROCEPT BioRobotics (PRCT) Investment Story Is Shifting After Q4 Miss And Guidance Reset - Yahoo Finance
Latest PRCT NewsPROCEPT BioRobotics Corporation Announces C... - Stock Titan
Assessing PROCEPT BioRobotics (PRCT) Valuation After Mixed Q1 2026 Results And Share Price Weakness - Sahm
PROCEPT BioRobotics Corp Q1 2026 Financial Results and SEC 10-Q Filing Highlights - Minichart
PROCEPT BioRobotics (PRCT)’s Growth Narrative Improves Following Aquablation Upgrade and HYDROS Launch - Insider Monkey
Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (PRCT), AbbVie (ABBV) and Humana (HUM) - The Globe and Mail
PROCEPT BioRobotics Q1 Loss Deepens To US$0.56 EPS And Tests Bullish Revenue Narratives - simplywall.st
Procept Biorobotics Charts Growth Amid Profit Pressures - TipRanks
PRCT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
PROCEPT BioRobotics (PRCT) CTO reports share and option stakes - Stock Titan
PROCEPT BioRobotics (NASDAQ: PRCT) Q1 2026 revenue rises 20% - Stock Titan
PROCEPT BioRobotics to Attend Three Upcoming Investor Conferences in May & June - Moomoo
PROCEPT BioRobotics® to Attend Three Upcoming Investor Conferences in May & June - The Manila Times
PROCEPT BioRobotics schedules 3 investor conference appearances - Stock Titan
10 Best Robotics Stocks to Buy Under $30 - Insider Monkey
PROCEPT BioRobotics (NASDAQ:PRCT) Shares Gap UpStill a Buy? - MarketBeat
Vanguard (NASDAQ: PRCT) holds 2.82M shares, a 5% stake - Stock Titan
Procept projects $390M-$410M 2026 revenue as Hydros pricing guides $450K-$460K for rest of year - MSN
Procept BioRobotics price target raised to $35 from $28 at Piper Sandler - TipRanks
PROCEPT BioRobotics Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
Earnings Call Summary | PROCEPT BioRobotics(PRCT.US) Q1 2026 Earnings Conference - Moomoo
PROCEPT BioRobotics (NASDAQ:PRCT) Posts Quarterly Earnings Results, Misses Estimates By $0.01 EPS - MarketBeat
PROCEPT BioRobotics Corporation (PRCT) reports Q1 loss, tops revenue estimates - MSN
PROCEPT BioRobotics Q1 Earnings Call Highlights - MarketBeat
Procept BioRobotics reports Q1 EPS (56c), consensus (55c) - TipRanks
Earnings call transcript: Procept Biorobotics Q1 2026 beats EPS expectations By Investing.com - Investing.com South Africa
Earnings call transcript: Procept Biorobotics Q1 2026 beats EPS expectations - Investing.com
12,200 U.S. procedures put PROCEPT BioRobotics' systems to work in Q1 - Stock Titan
PROCEPT BioRobotics Corporation (PRCT) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
PROCEPT BioRobotics Corporation (PRCT) Stock Rises on Q1 2026 Earnings - Quiver Quantitative
Earnings Flash (PRCT) PROCEPT BioRobotics Corporation Reports Q1 Revenue $83.1M, vs. FactSet Est of $80.5M - marketscreener.com
PROCEPT BioRobotics (Nasdaq: PRCT) grows Q1 2026 revenue 20% but stays loss-making - Stock Titan
PROCEPT BioRobotics Reports First Quarter 2026 Financial Results - The Manila Times
Procept Biorobotics in the spotlight as Q1 earnings test turnaround - Investing.com UK
Procept Biorobotics in the spotlight as Q1 earnings test turnaround By Investing.com - Investing.com Australia
Procept Biorobotics Corporation Reaffirms Earnings Guidance for the Year Ending December 31, 2026 - marketscreener.com
Robotics Stocks To Follow TodayApril 28th - MarketBeat
PROCEPT BioRobotics (PRCT) Price Target Decreased by 16.88% to 55.27 - MSN
PROCEPT BioRobotics (PRCT) price target decreased by 37.60% to 33.58 - MSN
59,200 Shares in PROCEPT BioRobotics Corporation $PRCT Bought by B. Metzler seel. Sohn & Co. AG - MarketBeat
PROCEPT BioRobotics (NASDAQ:PRCT) Rating Increased to Sell at Wall Street Zen - MarketBeat
Finanzdaten der Procept Biorobotics Corp-Aktie (PRCT)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):